Invivyd

Invivyd

Biotechnology Research

Waltham, Massachusetts 11,915 followers

Devoted to delivering protection from serious viral infectious diseases.

About us

Invivyd, Inc. (Nasdaq: IVVD) is a commercial-stage company is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases. Leveraging state-of-the-art viral surveillance, predictive modeling, and advanced antibody engineering techniques, we are taking a platform-based approach to the continuous discovery and optimization of monoclonal antibody candidates designed to protect the vulnerable from serious viral threats. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for its first mAb in a planned series of innovative antibody candidates. Visit https://invivyd.com/ to learn more.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Waltham, Massachusetts
Type
Public Company
Founded
2020

Locations

  • Primary

    1601 Trapelo Rd

    Suite 178

    Waltham, Massachusetts 02451, US

    Get directions

Employees at Invivyd

Updates

Similar pages

Browse jobs

Funding